About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
(C) 2024 MINKABU THE INFONOID, Inc.

Pharma Foods, August-October (1Q) Ordinary Profit Increases by 47%

Wed Dec 11, 2024 3:30 pm JST Earnings

2929 Pharma Foods International Co., Ltd. 【J-GAAP】

Earnings Report

Pharma Foods International Co., Ltd. <2929> [TSE Prime] announced its financial results after the market closed on December 11th (15:30). The consolidated ordinary profit for the first quarter of the fiscal year ending July 2025 (August to October) expanded 888 million yen, an increase 46.8% compared to the same period last year. The progress rate toward the full-year plan of 2.3 billion yen was 38.6%, also surpassing the progress rate of 11.5% from the same period of the previous year.

In the most recent three-month period, from August to October (1Q), the operating profit margin improved from 3.7% in the same period last year to 6.0%.

Kabutan News

Actual Results

Accumulated Results 1st Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Aug - Oct, 2022 17,030 -2,194 -2,180 -1,820 -62.8 ー Dec 5, 2022 J-GAAP
Aug - Oct, 2023 16,142 601 605 286 9.9 39.2 Dec 11, 2023 J-GAAP
Aug - Oct, 2024 14,596 882 888 360 12.9 ー Dec 11, 2024 J-GAAP
YoY -9.6% +46.8% +46.8% +25.9% +29.4%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Aug - Jan, 2023 31,652 1,535 1,542 768 26.7 10 Mar 11, 2024 J-GAAP
Aug - Jan, 2024 Guidance ー ー ー ー － 12.50 Sep 12, 2024 J-GAAP
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul, 2023 68,572 3,610 3,540 3,081 106.7 22 Sep 11, 2023 J-GAAP
Jul, 2024 62,147 5,113 5,249 3,205 112.7 25 Sep 12, 2024 J-GAAP
Jul, 2025 Guidance 65,000 2,000 2,300 1,600 55.0 25 Sep 12, 2024 J-GAAP
YoY +4.6% -60.9% -56.2% -50.1% -51.2%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Aug - Oct, 2023 16,142 601 605 286 9.9 3.7 Dec 11, 2023 J-GAAP
Nov - Jan, 2023 15,510 934 937 482 16.7 6.0 Mar 11, 2024 J-GAAP
Feb - Apr, 2024 15,519 1,731 1,681 1,088 38.1 11.2 Jun 10, 2024 J-GAAP
May - Jul, 2024 14,976 1,847 2,026 1,349 47.4 12.3 Sep 12, 2024 J-GAAP
Aug - Oct, 2024 14,596 882 888 360 12.9 6.0 Dec 11, 2024 J-GAAP
YoY -9.6% +46.8% +46.8% +25.9% +29.4%

Related Articles